main-logo

ICD-10 Code C84.18 | Sezary disease, lymph nodes of multiple sites Symptoms, Diagnosis, Billing

Sezary disease is a rare type of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating malignant T-cells. It is associated with significant morbidity and requires accurate diagnosis and documentation for effective management. The ICD-10 Code C84.18 facilitates precise coding for billing, clinical decision-making, and public health reporting, ensuring that healthcare providers can track and manage this complex condition appropriately.

What is ICD-10 Code C84.18 for Sezary disease, lymph nodes of multiple sites?

ICD-10 Code C84.18 specifically denotes Sezary disease affecting lymph nodes at multiple sites. This condition is a leukemic form of cutaneous T-cell lymphoma, presenting with systemic symptoms and extensive skin involvement. The code is utilized in clinical documentation and billing when diagnosing patients with this specific malignancy, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.

ICD-10 Code C84.18 – Clinical Definition and Explanation of Sezary disease, lymph nodes of multiple sites

Sezary disease is a severe form of cutaneous T-cell lymphoma that manifests with widespread skin lesions, lymphadenopathy, and the presence of atypical T-cells in the blood. The etiology is linked to genetic mutations and environmental factors, leading to a progressive and often debilitating condition that necessitates prompt medical intervention.

Key Clinical Features:

  • Erythroderma covering more than 80% of the body surface.
  • Lymphadenopathy in multiple regions, often palpable.
  • Presence of Sezary cells in peripheral blood.
  • Pruritus and skin lesions that may be scaly or crusted.

ICD-10 Code C84.18 for Sezary disease, lymph nodes of multiple sites – SOAP Notes & Clinical Use

In clinical workflows, ICD-10 Code C84.18 is essential for documenting the diagnosis of Sezary disease. It aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.

What Does ICD-10 Code C84.18 for Sezary disease, lymph nodes of multiple sites Mean in SOAP Notes?

ICD-10 Code C84.18 connects subjective patient reports and objective clinical findings to a formal diagnosis of Sezary disease. This code is crucial for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C84.18 – Sezary disease, lymph nodes of multiple sites

Sezary disease requires urgent medical attention, often necessitating hospitalization for management. Treatment may include systemic therapies tailored to the patient's condition.

Antibiotic Therapy:

  • First-line: Methotrexate (duration varies based on response).
  • Alternative: Gemcitabine (duration varies based on response).
  • Consideration of photopheresis as adjunctive therapy.

Supportive Care:

  • Management of pruritus with topical corticosteroids.
  • Hydration and skin care to prevent infections.
  • Psychosocial support for patients and families.

Infection Control:

  • Strict hygiene practices to prevent skin infections.
  • Isolation precautions if secondary infections are present.
  • Monitoring for opportunistic infections due to immunosuppression.

How to Document Symptoms of Sezary disease, lymph nodes of multiple sites (ICD-10 C84.18) in SOAP Notes

Subjective:

  • Patient reports persistent itching and discomfort.
  • History of skin lesions worsening over the past few months.
  • Complaints of fatigue and weight loss.
  • Family history of skin cancers or lymphomas.

Objective:

  • Erythroderma observed on physical examination.
  • Palpable lymphadenopathy in cervical and axillary regions.
  • Laboratory findings show elevated white blood cell count with atypical lymphocytes.
  • Skin biopsy confirms diagnosis of Sezary disease.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Sezary disease, lymph nodes of multiple sites (ICD-10 Code C84.18)

Assessment:

  • Diagnosis: Sezary disease, lymph nodes of multiple sites, classified as severe.
  • ICD-10 Code: C84.18.
  • Contributing factors include immunosuppression and environmental exposures.
  • Patient exhibits significant systemic symptoms.

Plan:

  • Initiate treatment with methotrexate and consider photopheresis.
  • Educate patient on skin care and infection prevention.
  • Schedule regular follow-up appointments for monitoring response to therapy.
  • Refer to oncology for specialized management.

Treatment & Plan Section for ICD-10 Code C84.18 – Sezary disease, lymph nodes of multiple sites

  • First-line pharmacologic treatment includes methotrexate or gemcitabine.
  • Non-pharmacologic strategies involve skin care and hydration.
  • Monitoring includes regular blood tests and skin assessments.
  • Follow-up practices should include oncology referrals and symptom tracking.

Using ICD-10 Code C84.18 for Sezary disease, lymph nodes of multiple sites in Billing & SOAP Note Compliance

  • Select appropriate subcodes based on clinical severity and complications.
  • Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
  • Ensure treatment plans align with clinical guidelines to support justified billing.
  • Commonly billed CPT codes include those for chemotherapy administration and consultations.

ICD-10 Code C84.18 in Medical Billing and Insurance for Sezary disease, lymph nodes of multiple sites

ICD-10 Code C84.18 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

  • Ensure documentation includes detailed patient history and clinical findings.
  • Use the code in settings where Sezary disease is diagnosed or treated.
  • Highlight key chart elements such as lab results and treatment plans.

Common CPT Pairings:

CPT CodeDescription
96413Chemotherapy administration, intravenous, push technique.
99203Office or other outpatient visit for evaluation and management.
96415Chemotherapy administration, intravenous, infusion technique.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C84.18 for Sezary disease, lymph nodes of multiple sites

What are the common symptoms of Sezary disease?

Common symptoms include widespread erythroderma, lymphadenopathy, severe itching, and the presence of atypical T-cells in the blood. Patients may also experience fatigue and weight loss.

How is Sezary disease diagnosed?

Diagnosis is typically made through clinical evaluation, skin biopsy, and blood tests showing Sezary cells. Imaging studies may also be used to assess lymph node involvement.

What treatments are available for Sezary disease?

Treatment options include systemic therapies such as methotrexate, photopheresis, and supportive care to manage symptoms. Treatment plans are individualized based on disease severity.

Is Sezary disease contagious?

No, Sezary disease is not contagious. It is a malignancy of T-cells and does not spread from person to person.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved